Validation of the Gross Motor Function Measure for use in children and adolescents with traumatic brain injuries

Michaela Linder-Lucht1, Verena Othmer, Michael Walther

  • 1Division of Neuropediatrics and Muscular Disorders, Department of Pediatrics and Adolescent Medicine, University Hospital Freiburg, Mathildenstrasse 1, D-79106 Freiburg, Germany. michaela.linder@uniklinik-freiburg.de

Pediatrics
|October 3, 2007
PubMed

Insights

The Gross Motor Function Measure (GMFM) is a valid tool for assessing motor function recovery in children and adolescents with traumatic brain injury (TBI). This study confirms its responsiveness and reliability for this patient group.

Area of Science:

  • Pediatric rehabilitation
  • Neuroscience
  • Clinical assessment

Background:

  • Motor function recovery is crucial for children and adolescents with traumatic brain injury (TBI).
  • Validated outcome measures are needed to assess treatment effectiveness in pediatric TBI.
  • The Gross Motor Function Measure (GMFM) shows promise but requires validation for TBI.

Purpose of the Study:

  • To validate the Gross Motor Function Measure (GMFM) for pediatric patients with traumatic brain injury (TBI).
  • To assess the responsiveness and psychometric properties of the GMFM in this population.

Main Methods:

  • Seventy-three pediatric patients with moderate-to-severe TBI were assessed twice with the GMFM-88 over 4-6 weeks.
  • External standards included parent, physiotherapist, and video assessor judgments of change.
  • Correlation and reliability analyses were performed for GMFM-88 and GMFM-66.

Main Results:

  • GMFM change scores significantly correlated with all external judgments of change.
  • The GMFM-88 and GMFM-66 demonstrated convincing discriminative capability.
  • Excellent test-retest reliability was observed for both GMFM versions.

Conclusions:

  • The Gross Motor Function Measure (GMFM) is a responsive and valid measure for assessing gross motor function in pediatric TBI.
  • Both GMFM-88 and GMFM-66 versions are suitable for use in this patient population.
Abstract